Ann McDermott, DO
Family Medicine · Chicago, ILNPI 1437109204
Payments from drug & device makers
Across 107 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$504
- AbbVie$223
- Pfizer$163
- Dexcom, Inc.$158
- GSK$155
- Abbott$118
- plus $913 from 22 others
What the payments were for
- Food & beverage$2,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $504 |
| AbbVie | 9 | $223 |
| Pfizer | 7 | $163 |
| Dexcom, Inc. | 6 | $158 |
| GSK | 8 | $155 |
| Abbott | 6 | $118 |
| Lilly USA, LLC | 5 | $110 |
| Astellas Pharma US Inc | 4 | $93 |
| Merck | 4 | $75 |
| Bayer | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 3 | $68 |
| Novartis | 3 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Dynavax Technologies Corporation | 2 | $31 |
| Biogen | 1 | $29 |
| VBI Vaccine (delaware) Inc. | 2 | $27 |
| Amgen | 1 | $26 |
| Exact Sciences | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$2,233 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $717 |
| Ibandronate Sodium | 20 | $680 |
| Atorvastatin Calcium | 45 | $523 |
| Omeprazole | 19 | $430 |
| Duloxetine Hcl | 14 | $360 |
| Rosuvastatin Calcium | 11 | $345 |
| Gabapentin | 16 | $311 |
| Lisinopril | 23 | $287 |
| Levothyroxine Sodium | 41 | $277 |
| Celecoxib | 18 | $250 |
| Amlodipine Besylate | 40 | $240 |
| Losartan Potassium | 13 | $234 |
| Chlorthalidone | 11 | $208 |
| Triamcinolone Acetonide | 11 | $205 |
| Simvastatin | 15 | $190 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chicago
- Bradley TorphyChicago$3M
- Frank PhillipsChicago$1.6M
- Ayoade AkereChicago$484K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Jacqueline OlivoChicago$165K
- Sameer PanjwaniChicago$136K
- Igor AltmanChicago$64K
- Juan RojasChicago$40K
- Mark SimonChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.